CHIAPPALUPI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 1.649
EU - Europa 1.292
AS - Asia 1.176
SA - Sud America 273
AF - Africa 29
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.432
Nazione #
US - Stati Uniti d'America 1.589
SG - Singapore 505
IT - Italia 463
BR - Brasile 234
IE - Irlanda 205
CN - Cina 192
HK - Hong Kong 176
RU - Federazione Russa 112
DE - Germania 104
KR - Corea 86
SE - Svezia 60
VN - Vietnam 51
FI - Finlandia 45
GB - Regno Unito 42
NL - Olanda 42
RO - Romania 37
CA - Canada 33
FR - Francia 33
AT - Austria 31
UA - Ucraina 30
IN - India 25
JP - Giappone 23
TR - Turchia 22
MX - Messico 18
PH - Filippine 18
PL - Polonia 18
ES - Italia 16
BE - Belgio 14
AR - Argentina 12
ZA - Sudafrica 11
BD - Bangladesh 10
IQ - Iraq 10
CH - Svizzera 9
CO - Colombia 7
EC - Ecuador 7
AU - Australia 6
IR - Iran 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
LB - Libano 5
MD - Moldavia 5
PK - Pakistan 5
TW - Taiwan 5
CZ - Repubblica Ceca 4
ID - Indonesia 4
IL - Israele 4
PY - Paraguay 4
TN - Tunisia 4
UZ - Uzbekistan 4
AL - Albania 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
DO - Repubblica Dominicana 3
EG - Egitto 3
GR - Grecia 3
HU - Ungheria 3
KH - Cambogia 3
LT - Lituania 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PA - Panama 3
EU - Europa 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NP - Nepal 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
BY - Bielorussia 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
GT - Guatemala 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
LV - Lettonia 1
MW - Malawi 1
NO - Norvegia 1
PE - Perù 1
SN - Senegal 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 4.432
Città #
Singapore 369
Chandler 253
Dublin 201
Perugia 193
Hong Kong 167
Ashburn 101
San Mateo 89
Santa Clara 77
Boardman 76
Moscow 47
Beijing 45
Dearborn 44
Redmond 44
Medford 41
Altamura 40
Ann Arbor 40
Munich 40
Princeton 40
Los Angeles 38
Wilmington 38
Seoul 36
Bucharest 34
The Dalles 33
Bologna 27
Vienna 27
Andover 26
New York 26
Lawrence 23
São Paulo 23
Falls Church 19
Seongnam-si 19
Ho Chi Minh City 17
Tokyo 17
Piscataway 15
Brussels 14
Falkenstein 13
Montreal 13
Amsterdam 12
Norwalk 12
Cebu City 11
Helsinki 11
Nuremberg 11
Brooklyn 10
Phoenix 10
Saint Petersburg 10
Warsaw 10
Hanoi 9
Johannesburg 9
Milan 9
Parma 9
Redwood City 9
Rome 9
Boston 8
Dallas 8
Groningen 8
Houston 8
Istanbul 8
Jacksonville 8
Tijuana 8
Turku 8
Brasília 7
Columbus 7
Hefei 7
Rio de Janeiro 7
Stockholm 7
Toronto 7
Atlanta 6
Collazzone 6
Denver 6
Des Moines 6
Glasgow 6
Incheon 6
London 6
Mumbai 6
Trinity 6
Dong Ket 5
Orem 5
Salvador 5
San Francisco 5
Turin 5
Vicenza 5
Woodbridge 5
Belo Horizonte 4
Chennai 4
Dumaguete 4
Fremont 4
Guarulhos 4
Jinju 4
Konya 4
Kunming 4
Lappeenranta 4
Olomouc 4
Ottawa 4
Paris 4
Shanghai 4
Simi Valley 4
Xiamen 4
Ankara 3
Auckland 3
Baghdad 3
Totale 2.780
Nome #
Intraperitoneal injection of microencapsulated Sertoli cells restores muscle morphology and performance in dystrophic mice 150
Histological muscle characterization in hypertrophied Marchigiana cattle breed 141
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 136
RAGE in the pathophysiology of skeletal muscle. 124
Generation of an mdx/Ager–/– double mutant mouse. Preliminary data on skeletal muscle architecture. 121
Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia 121
Sertoli cells protect C2C12 myotubes against atrophy and induce utrophin expression in canine and human dystrophic myotubes. 120
Identification of natural products able to counteract the formation of advanced glycation end-products (AGEs) sustaining muscle atrophy 117
S100B protein regulates myoblast and macrophage functions in skeletal muscle regeneration 115
Toward the identification of receptor for advanced glycation end-products (RAGE) as a muscle biomarker of cancer cachexia. 112
RAGE and its ligands, S100B and HMGB1, are molecular determinants of cancer-induced muscle wasting. 108
Equisetum arvense standardized extract hinders age-related sarcopenia 107
Natural products to counteract muscle atrophy 106
Targeting RAGE as a potential therapeutic approach to Duchenne muscular dystrophy 105
Sertoli cell-secreted factors have promyogenic and antifibrotic properties on human DMD myoblasts with different mutations. 102
Pharmacological targeting of the receptor for advanced glycation end-products (RAGE) to counteract cancer cachexia 100
Absence of RAGE in an animal experimental model of Duchenne muscular dystrophy results in reduced muscle necrosis and inflammation 100
Beneficial effects of horsetail (Equisetum arvense) in experimental models of sarcopenia and osteoporosis 97
Microencapsulated Sertoli cells sustain myoblast proliferation without affecting the myogenic potential. In vitro data 96
Effects of intraperitoneal injection of microencapsulated Sertoli cells on chronic and presymptomatic dystrophic mice 91
Transplantation of microencapsulated Sertoli cells: a new potential antiinflammatory approach to Duchenne muscular dystrophy (DMD). 89
Identification of Withania somnifera-Silybum marianum-Trigonella foenum-graecum Formulation as a Nutritional Supplement to Contrast Muscle Atrophy and Sarcopenia 88
KYMASIN UP Natural Product Inhibits Osteoclastogenesis and Improves Osteoblast Activity by Modulating Src and p38 MAPK 86
Levels of S100B protein drive the reparative process in acute muscle injury and muscular dystrophy 86
The receptor RAGE: a potential molecular target in cancer cachexia 85
Employment of Microencapsulated Sertoli Cells as a New Tool to Treat Duchenne Muscular Dystrophy 84
Do porcine Sertoli cells represent an opportunity for Duchenne muscular dystrophy? 84
Mdx/Ager–/– mice show reduced muscle necrosis and inflammation compared with mdx mice 81
The effects of microgravity on human skeletal muscle regeneration. 81
Transplantation of microencapsulated Sertoli cells in mdx mice reduces muscle inflammation and promotes muscle regeneration 81
Hyperactivated rage in comorbidities as a risk factor for severe covid-19—the role of rage-ras crosstalk 78
Defective RAGE activity in embryonal rhabdomyosarcoma cells results in high PAX7 levels that sustain migration and invasiveness 77
S100 proteins in obesity: liaisons dangereuses 76
Involvement of a RAGE/p38MAPK/myogenin axis in cancer cachexia. 76
Use of Sertoli cells to treat DMD patients is supported by their immunomodulatory rather than immunosuppressive effect 76
Receptor for advanced glycation end-products (RAGE) as a biomarker of muscle wasting in cancer conditions 75
HEREGULIN-INDUCED UTROPHIN UPREGULATION PROMOTES RECOVERY OF MUSCLE HOMEOSTASIS IN MDX MICE TRANSPLANTED WITH MICROENAPSULATED SERTOLI CELLS 74
Reductive stress in striated muscle cells 74
Transplantation of microencapsulated Sertoli cells in a mouse model of Duchenne muscular dystrophy (DMD) reduces inflammation and rescues muscle performance. 72
Ablation of RAGE (receptor for advanced glycation end-products) translates into reduced tumorigenic and cachectic potential in LLC-tumor bearing mice 71
Novel data support the use of microencapsulated Sertoli cells as a potential treatment of DMD patients. 69
Equisetum arvense standardized dried extract hinders age-related osteosarcopenia. 68
RAGE expression in rhabdomyosarcoma cells modulates metastasis formation in vivo. 61
Self-powered temperature sensors harnessing membrane potential of living cells 60
The novel DMD experimental model, mdx/Ager–/– mouse reveals a role of RAGE in inflammatory processes in dystrophic muscles. 60
Intraperitoneal transplantation of microencapsulated Sertoli cells counteracts muscle inflammation and rescues muscle performance in mdx mice. 59
Sertoli cells induce utrophin expression in human DMD myotubes with different mutations and exert promyogenic and antifibrotic effects 58
Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives 54
Beneficial effects of horsetail (Equisetum arvense) in in vitro models of sarcopenia and osteoporosis 50
Sertoli cells improve myogenic differentiation, reduce fibrogenic markers, and induce utrophin expression in human dmd myoblasts 48
Grafted Sertoli Cells Exert Immunomodulatory Non-Immunosuppressive Effects in Preclinical Models of Infection and Cancer 45
Sertoli cells have promyogenic and antifibrotic effects, and induce utrophin expression in human DMD myotubes with different mutations in a heregulin β1/ErbB2/ERK1/2-dependent manner 38
The MyoGravity project to study real microgravity effects on human muscle precursor cells and tissue 36
Preparation of Human Muscle Precursor Cells for the MyoGravity Project - Cell Culture in Experiment Units for Space Flight Purpose 36
Totale 4.605
Categoria #
all - tutte 20.080
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.080


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021115 0 0 0 0 0 31 34 4 21 11 7 7
2021/2022420 4 65 9 19 12 12 12 106 12 39 58 72
2022/2023717 43 128 5 64 60 77 1 34 269 2 27 7
2023/2024387 18 28 9 35 18 12 102 8 19 24 37 77
2024/20251.448 46 103 148 84 166 68 136 153 195 87 186 76
2025/2026985 140 116 96 276 308 49 0 0 0 0 0 0
Totale 4.605